Scientific Company Directory

Scientific Company Directory

The latest research, products, and discoveries from the science industry’s leading companies and company divisions.

NEW

Scientific Products

From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.

Search Scientific Products
  • ALL
    • |
  • A
    • |
  • B
    • |
  • C
    • |
  • D
    • |
  • E
    • |
  • F
    • |
  • G
    • |
  • H
    • |
  • I
    • |
  • J
    • |
  • K
    • |
  • L
    • |
  • M
    • |
  • N
    • |
  • O
    • |
  • P
    • |
  • Q
    • |
  • R
    • |
  • S
    • |
  • T
    • |
  • U
    • |
  • V
    • |
  • W
    • |
  • X
    • |
  • Y
    • |
  • Z

    • Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

    The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.

    Sapio Sciences' mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware (TM) lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.

    Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.

    Customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs. For more information, visit www.sapiosciences.com and follow us on LinkedIn.

    Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis. With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.

    SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine (DDM) to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare disease management, the SOPHiA DDMTM platform allows clinical researchers to act with precision and confidence. The company’s innovative approach and patented machine learning-based algorithms enable a community of more than 750 institutions to share knowledge, fostering a new era in healthcare.

    Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.

    SPT Labtech designs and manufactures robust, reliable and easy-to-use solutions for liquid handling, sample preparation and management, plus cryo-EM.

    SciNote LLC is a trusted provider of lab digitalization solutions for government, industry, and academic research laboratories. Its electronic lab notebook software is globally recognized and used by the FDA, USDA, and over 90K+ researchers in more than 100 countries. It has been evaluated and acclaimed by biotech, biopharma, healthcare, and life science companies for its user-friendly interface, advanced features, dependable performance, robust security, and ability to meet the evolving needs of labs as they grow. Moreover, the SciNote team takes pride in their unparalleled user-satisfaction rate and their team of scientifically trained customer-success specialists that labs genuinely enjoy collaborating with.

    Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
    Founded in 2021 and headquartered in Woburn, Massachusetts, Spear Bio is dedicated to its mission of revolutionizing biomarker research and diagnostics through innovation and accessibility. Leveraging its unique homogeneous assay format, SPEAR technology consistently delivers highly sensitive and precise protein measurements. Spear Bio envisions a future where high-performance assays democratize access to critical insights, accelerating progress in research and medicine worldwide. For further information, please visit www.spear.bio or email info@spear.bio
    SCIEX has led the field of mass spectrometry and capillary electrophoresis for over 50 years, pioneering innovative solutions for the precision detection of quantification of molecules. Our products and services have supported thousands of scientists and influenced life-changing research that has positively impacted the lives of people around the world.
    Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers obtain the best reagents in the needed amounts to accelerate the pace of discovery and improve human health.
    Fluidigm creates and manufactures innovative technologies and life-science tools designed to revolutionize biology through a relentless pursuit of scientific truth. Its core technologies are based on microfluidics and mass cytometry, and enable the exploration and analysis of individual cells, as well as the industrial application of genomics.
    Shimadzu Corporation has remained committed to commercializing cutting-edge technology and providing it to customers in a wide array of industries for more than 140 years.
    Synthego's vision is to turn biology into an information science, with the ultimate goal of dramatically extending the healthy human lifespan. Synthego builds advanced bioinformatics and automated hardware platforms to create next-generation molecular biology tools, starting with full-stack genome engineering. These world-class tools accelerate basic scientific discovery, critical disease cures and novel synthetic biology applications to improve and prolong life.

    Siemens Healthineers is a leading medtech company with over 125 years of experience. Their portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), they are well positioned to take on the biggest challenges in healthcare. They will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.

    sphingotec GmbH aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney function. In order to realize this mission we provide biomarkers indicating susceptibility for a specific disease which enables the monitoring of prevention and intervention strategies. The company was established in 2002 by Dr. Andreas Bergmann who is one of the founders and managers of B.R.A.H.M.S. Aktiengesellschaft where, in addition to several other biomarkers, the sepsis marker Procalcitonin (B.R.A.H.M.S PCT®) was developed in his role as Chief Research Officer. This biomarker Procalcitonin created a new diagnostic standard of care supporting patient management in sepsis. sphingotec is located in Hennigsdorf, northwest of Berlin, Germany, with its facilities in the Technology Campus one of the largest industrial parks in Berlin and Brandenburg with several companies of the biotechnology branch located there.
    STEMCELL Technologies Inc. is a Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalogue of more than 2000 cell biology research tools. STEMCELL Technologies was launched in 1993 when founder and CEO Allen Eaves needed a way to meet the increasing demands for his standardized, cost-effective cell culture media for growing blood-forming stem cells. At the time, Eaves was a hematologist and cancer researcher heading the Terry Fox Laboratories (TFL) and head of clinical hematology at the University of British Columbia in Vancouver, Canada. Unsatisfied with commercially available cell culture reagents, Eaves' research group at the TFL began making their own hematopoietic stem cell culture media using the highest quality materials they could find. Colleagues also wanted to use this media, and Eaves was able to supplement his research funds by selling culture media to other lab groups. Eventually the demand for the media from researchers around the world warranted building a designated clean room for production. The TFL did not have the funding and instead, Eaves was encouraged to purchase the business and create an independent company. Mortgaging his house and receiving a loan from Western Economic Diversification, Eaves was able to build a clean room and STEMCELL Technologies Inc. was born on July 2, 1993. STEMCELL has become the largest biotech company in Canada and continues to reinvest all profits back into developing products to better support the international research community. As of 2017, the company employs more than 1000 people globally, with over one-third of those holding a PhD or MSc, and the majority of employees having a BSc or Engineering degree. A large number of the company's employees are located in Vancouver, Canada with additional employees and facilities in 11 other countries.

    Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest-growing industries. We are a publicly traded life science technology company that is leveraging novel, next-generation sequencing (NGS) and multi-omics technologies to build products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. We are committed to unlocking the potential of our core technologies to reshape the future of genomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact in a rapidly expanding company. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.

    The Society of Laboratory Animal Veterinary Technicians (SLAVT) is a group focused on National recognition through training and certification for veterinary technicians in the field of laboratory animal medicine. This goal was achieved with the creation of the Veterinary Technician Specialty (VTS) Academy of Laboratory Animal Veterinary Technicians and Nurses (ALAVTN). It is the mission of SLAVT is to enhance animal welfare; sharing of clinical, surgical and technical ideas amongst its membership, continuing education, and professional networking among laboratory animal technicians. This mission is shared with ALAVTN with the main focus to promote excellence by specialization in veterinary technology/nursing in the distinct field of Laboratory Animal Medicine by demonstrating advance proficiency of skill level and knowledge base.
    seqWell was created to revolutionize NGS library prep to unlock the full potential of today's DNA sequencing instruments. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes. In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.
    System Biosciences (SBI) develops innovative research tools for MicroRNA research, Exosome research, and Genome Engineering tools, including the CRISPR-Cas9 SmartNuclease system and PrecisionX HR targeting vectors. SBIs ExoQuick Exosome precipitation reagent is the most highly published reagent for exosome isolation in the world, with dozens of product citations in top journals. SBI also specializes in biomarker discovery with our unique Exo-NGS service, offering an end-to-end solution starting with patient samples and delivering comprehensive data analytics on NGS sequencing of exosomal RNA libraries.
    StressMarq Biosciences is a life sciences company with a diverse portfolio of primary antibodies, proteins, immunoassay kits and small molecules for scientific research in areas including cancer research, cardiovascular disease, cell signaling and neuroscience. StressMarq has recently developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research, including proteins such as alpha synuclein, tau, SOD1 and TTR. Our strategic efforts are currently focused on being a world leader in the manufacturing and marketing of fibrilized proteins (and their derivatives), protein oligomers, and antibodies to fibrilizing proteins to assist researchers studying Alzheimer's, Parkinson's, and other neurodegenerative diseases.
    Sysmex is the recognized, global leader of in vitro diagnostic hematology systems. Our corporate mission is to shape the advancement of healthcare and we accomplish this by partnering in academic and industrial research and through clinical diagnostics. Our expertise in cellular analysis, from counting to identification, results in our industry-leading technologies utilizing flow cytometry and fluorescence. Sysmex is committed to advancements in flow cytometry, building upon our hematology knowledge and strengthened by our acquisition of Partec GmbH, a pioneer in flow cytometry. Our comprehensive line of flow cytometry products includes analyzers (CyFlow® Cube and CyFlow® Space), consumables (CellTrics® filters) and reagents (CyFlow™ monoclonal antibodies, lysing solutions).